C-peptide and long-term complications of diabetes (Q37815562)

23 August 2017

1 reference

title

C-peptide and long-term complications of diabetes (English)

1 reference

23 August 2017

3

John Wahren

1 reference

23 August 2017

Patrizia Luppi

1

1 reference

PubMed ID

21129141

23 August 2017

Vincenza Cifarelli

series ordinal

2

1 reference

23 August 2017

5 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

12

1 reference

23 August 2017

3 Pt 2

1 reference

23 August 2017

276-292

1 reference

Insulin biosynthesis: evidence for a precursor

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Separate functional features of proinsulin C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin and C-peptide: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Identical twins discordant for type 1 diabetes show a different pattern of in vitro CD56+ cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The role of inflammation in insulitis and beta-cell loss in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Macrophages from high-risk HLA-DQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Increased Expression of Monocyte CD11b (Mac-1) in Overweight Recent-Onset Type 1 Diabetic Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The discovery of nitric oxide as the endogenous nitrovasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The many faces of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

New insights into the metabolic and molecular basis for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Type 1 diabetic neuropathy and C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Pain in peripheral neuropathy related to rate and kind of fiber degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Diabetic nephropathy: diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Effects of C-peptide on glomerular and renal size and renal function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Influence of C-peptide on early glomerular changes in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide binding to human cell membranes: importance of Glu27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Specific binding of proinsulin C-peptide to human cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Cellular internalization of proinsulin C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin C-peptide regulates ribosomal RNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Molecular basis for the insulinomimetic effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00729.X

10.1111/J.1399-5448.2010.00729.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21129141